Bank of Montreal
STOK icon

Bank of Montreal’s Stoke Therapeutics STOK Stock Holding History

Bank of Montreal’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,055
Closed -$287K – 4014
2025
Q4 		$287K Buy
+9,055
New +$272K ﹤0.01% 2617
2023
Q1 		– Sell
-427,888
Closed -$3.96M – 4165
2022
Q4 		$3.96M Sell
427,888
-341,400
-44% -$3.55M ﹤0.01% 1420
2022
Q3 		$11.4K Sell
769,288
-243,783
-24% -$3.89M ﹤0.01% 926
2022
Q2 		$13.8K Buy
+1,013,071
New +$15.4M 0.01% 915
2021
Q2 		– Sell
-515
Closed -$18K – 4815
2021
Q1 		$18K Sell
515
-1,407
-73% -$80.1K ﹤0.01% 4105
2020
Q4 		$112K Buy
1,922
+1,359
+241% +$62.3K ﹤0.01% 3527
2020
Q3 		$20K Sell
563
-414
-42% -$11.8K ﹤0.01% 3844
2020
Q2 		$23K Buy
+977
New +$23.2K ﹤0.01% 3794
2020
Q1 		– Sell
-1,155
Closed -$33K – 4666
2019
Q4 		$33K Buy
+1,155
New +$29K ﹤0.01% 4040

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bank of Montreal's STOK Position: Q1 2026 in Review

Bank of Montreal sold out of Stoke Therapeutics (STOK) in Q1 2026, closing a stake of 9,055 shares — an estimated $287K sold.

Bank of Montreal first reported a position in STOK in Q4 2019 and held it in 9 quarters. The position peaked at $3.96M in Q4 2022. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Bank of Montreal reported no remaining Stoke Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 9,055 Stoke Therapeutics shares in Q1 2026, an estimated $287K.
  • Bank of Montreal first reported a position in Stoke Therapeutics in Q4 2019 and held it in 9 quarters.
  • Bank of Montreal's Stoke Therapeutics position peaked at $3.96M in Q4 2022.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.